Inventor · disambiguated record
Philippe Pflieger
Also filed as: PFLIEGER PHILIPPE
55 granted patents·16 pending applications·147 citations·filing 1995–2024
98Inventor score
Top patents by PatentIndex Score
71 records- 0191US7265125B2Neuropeptide Y antagonistsHOFFMANN LA ROCHE·Filed 2005·Granted Sep 4, 2007·18 cites·45 claims
- 0287US6821980B1Substituted 5-benzyl-2,4-diaminopyrimidinesBASILEA PHARMACEUTICA AG·Filed 2000·Granted Nov 23, 2004·30 cites·28 claims
- 0380US9790230B22-oxa-5-azabicyclo[2.2.1]heptan-3-yl derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Oct 17, 2017·3 cites·10 claims
- 0480US7166589B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Jan 23, 2007·3 cites·19 claims
- 0580US7064134B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Jun 20, 2006·3 cites·20 claims
- 0679US9029370B2Substituted benzamide derivativesGALLEY GUIDO·Filed 2012·Granted May 12, 2015·4 cites·13 claims
- 0779US7678818B2Anthranilamide and 2-amino-heteroarene-carboxamide compoundsHOFFMANN LA ROCHE·Filed 2007·Granted Mar 16, 2010·4 cites·20 claims
- 0879US6696467B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Feb 24, 2004·12 cites·22 claims
- 0978US7294644B2CB 1 receptor inverse agonistsHOFFMANN LA ROCHE·Filed 2003·Granted Nov 13, 2007·10 cites·26 claims
- 1077US11390604B2Imidazole-pyrazole derivativesHOFFMANN LA ROCHE·Filed 2020·Granted Jul 19, 2022·1 cites·31 claims
- 1177US9840501B2Morpholin-pyridine derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Dec 12, 2017·2 cites·12 claims
- 1277US7674815B2Heteroaryl and benzyl amide compoundsHOFFMANN LA ROCHE·Filed 2007·Granted Mar 9, 2010·4 cites·20 claims
- 1376US7259183B2Indole, indazole and indoline derivatives as CETP inhibitorsHOFFMANN LA ROCHE·Filed 2005·Granted Aug 21, 2007·4 cites·5 claims
- 1474US7572823B2Heteroaryl carboxamide compoundsHOFFMANN LA ROCHE·Filed 2007·Granted Aug 11, 2009·2 cites·16 claims
- 1574US6787558B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Sep 7, 2004·5 cites·26 claims
- 1673US8802673B2Heterocyclic amine derivativesGALLEY GUIDO·Filed 2012·Granted Aug 12, 2014·2 cites·30 claims
- 1773US7786128B2Indole or benzimidazole derivatives as CB1 inverse agonistsHOFFMANN LA ROCHE·Filed 2008·Granted Aug 31, 2010·2 cites·12 claims
- 1873US7579369B2CB 1 receptor inverse agonistsHOFFMANN LA ROCHE·Filed 2007·Granted Aug 25, 2009·1 cites·26 claims
- 1973US6818767B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Nov 16, 2004·5 cites·88 claims
- 2072US11312711B2Morpholine derivativeHOFFMANN LA ROCHE·Filed 2020·Granted Apr 26, 2022·0 cites·19 claims
- 2172US9452980B2Substituted benzamidesGROEBKE ZBINDEN KATRIN·Filed 2010·Granted Sep 27, 2016·2 cites·14 claims
- 2272US7253197B2Aminothiazole derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Aug 7, 2007·5 cites·6 claims
- 2371US7745477B2Heteroaryl and benzyl amide compoundsHOFFMANN LA ROCHE·Filed 2007·Granted Jun 29, 2010·1 cites·17 claims
- 2470US7012073B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Mar 14, 2006·3 cites·20 claims
- 2567US10023559B2Substituted azetidine derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Jul 17, 2018·1 cites·4 claims
- 2665US2024366581A1Benzimidazole pyridine derivativesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2765US2024376073A1Quaternary ammonium cation substituted compounds for the treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2864US8883786B2Glucocorticoid receptor antagonistsBAILLY JACQUES·Filed 2012·Granted Nov 11, 2014·1 cites·13 claims
- 2962US6657060B2Pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2001·Granted Dec 2, 2003·1 cites·60 claims
- 3062US2023257354A1Novel heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 3161US2023141600A1Imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3260US5494666Aβ-lactam compoundsHOFFMANN LA ROCHE·Filed 1995·Granted Feb 27, 1996·7 cites·75 claims
- 3360US2024383875A1Benzimidazole Pyridine DerivativesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 3459US10508107B2Morpholine derivativeHOFFMANN LA ROCHE·Filed 2018·Granted Dec 17, 2019·0 cites·22 claims
- 3559US2023203043A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3658US10501411B2Substituted benzamidesHOFFMANN LA ROCHE·Filed 2016·Granted Dec 10, 2019·0 cites·10 claims
- 3758US2022396565A1Novel heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3855US6218379B1Tricyclic carbacephemsHOFFMANN LA ROCHE·Filed 1997·Granted Apr 17, 2001·6 cites·124 claims
- 3954US10316036B2Substituted pyrazino[2,2-a]isoquinoline derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Jun 11, 2019·0 cites·8 claims
- 4054US8143280B2Glucocorticoid receptor antagonistsBAILLY JACQUES·Filed 2008·Granted Mar 27, 2012·0 cites·13 claims
- 4154US2013172335A12,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compoundsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 4254US2023012368A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4353US8178583B2CompoundsHOFFMANN TORSTEN·Filed 2009·Granted May 15, 2012·0 cites·20 claims
- 4453US7384945B2Indole or benzimidazole derivatives as CB1 inverse agonistsHOFFMANN LA ROCHE·Filed 2005·Granted Jun 10, 2008·0 cites·13 claims
- 4553US2023022724A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4653US2023017532A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4753US2023011869A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4853US2005049413A1Quinoline derivativesFiled 2004·Application pending·0 cites
- 4952US9828374B2Substituted pyrazino[2,2-a]isoquinoline derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Nov 28, 2017·0 cites·4 claims
- 5052US8450313B22,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compoundsHUNZIKER DANIEL·Filed 2012·Granted May 28, 2013·0 cites·19 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →